Aclarion, Inc. (ACON) stock

ACONNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACONW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30

$1.56−0.03 (-1.89%)

Close on Nov 13, 2026Market cap $4.50MP/E –Yield –

Aclarion total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Aclarion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ACON.

Revenue growth46.0% · median -3.7%

Operating margin-10789.2% · median -21365.1%

Net margin-10260.0% · median -18978.1%

Advertisement
300 × 250

See a number that looks wrong?